Fabien Xuereb
- Pharmacology top 5%
- Epidemiology
- Infectious Diseases top 10%
- Molecular Medicine top 5%
- Applied Microbiology and Biotechnology top 2%
- Co-authors
- Dominique BreilhMarie‐Claude SauxSarah DjabaroutiBernard AllaouchicheEmmanuel BoselliThomas RimmeléC. GuillauméD. Chassard
- Topics
- Antibiotics Pharmacokinetics and Efficacy (9 papers)Pharmaceutical Practices and Patient Outcomes (6 papers)Pneumonia and Respiratory Infections (4 papers)
- Journals
- Antimicrobial Agents and ChemotherapyCritical Care MedicineInternational Journal of Pharmaceutics
- Partner nations
- FranceBelizeUnited States
In The Last Decade
Fabien Xuereb
38 papers receiving 588 citations
Peers
Comparison fields: 5 of 73
- Pharmacology 319
- Epidemiology 238
- Infectious Diseases 203
- Molecular Medicine 134
- Applied Microbiology and Biotechnology 79
Countries citing papers authored by Fabien Xuereb
This map shows the geographic impact of Fabien Xuereb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fabien Xuereb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fabien Xuereb more than expected).
Fields of papers citing papers by Fabien Xuereb
This network shows the impact of papers produced by Fabien Xuereb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fabien Xuereb. The network helps show where Fabien Xuereb may publish in the future.
Co-authorship network of co-authors of Fabien Xuereb
This figure shows the co-authorship network connecting the top 25 collaborators of Fabien Xuereb. A scholar is included among the top collaborators of Fabien Xuereb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fabien Xuereb. Fabien Xuereb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 1 | |
| 5 | 3 | |
| 6 | 4 | |
| 7 | 0 | |
| 8 | 1 | |
| 9 | 0 | |
| 10 | 2 | |
| 11 | 1 | |
| 12 | 48 | |
| 13 | 11 | |
| 14 | 1 | |
| 15 | 7 | |
| 16 | 69 | |
| 17 | 62 | |
| 18 | 28 | |
| 19 | 76 | |
| 20 | 32 |
About Fabien Xuereb
Fabien Xuereb is a scholar working on Family Practice, Geriatrics and Gerontology and Applied Microbiology and Biotechnology, having authored 42 papers that have together received 605 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (9 papers), Pharmaceutical Practices and Patient Outcomes (6 papers) and Pneumonia and Respiratory Infections (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (79 citations), Molecular Medicine (134 citations) and Pharmacology (319 citations). Fabien Xuereb has collaborated with scholars based in France, Belize and United States. Frequent co-authors include Dominique Breilh, Marie‐Claude Saux, Sarah Djabarouti, Bernard Allaouchiche, Emmanuel Boselli, Thomas Rimmelé, C. Guillaumé, D. Chassard, Isabelle Pellegrin and Hélène Budzinski. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Critical Care Medicine and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.